Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gastrointestinal 1

Conditions

Neoplasms 3Trigger Finger Disorder 1Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Ganglion Cysts 1Esthesioneuroblastoma, Olfactory 1Dupuytren Contracture 1De Quervain Disease 1Colorectal Neoplasms 1Cognitive Dysfunction 1Carpal Tunnel Syndrome 1Cachexia 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Ibuprofen × Clear all
NCT03186638 2023-09-25

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

University of Rochester

Phase 2 Completed
87 enrolled 13 charts

Neoplasms, Cognitive Dysfunction

NCT04907864 2021-06-01

MIRACLE

Kyunghee University Medical Center

Phase 2 Unknown
112 enrolled
GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01238120 2021-05-05

The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients

University of Rochester

Phase 2 Completed
110 enrolled 15 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡